Literature DB >> 18309005

BK virus nephritis after renal transplantation.

Aaron Dall1, Sundaram Hariharan.   

Abstract

BK virus nephritis is an increasing problem and is posing a threat to improving renal transplant graft survival. The pathogenesis of this condition remains to be investigated. Higher prevalence of BK virus infection in recent years has been correlated with declining acute rejection rates and the use of potent immunosuppressive agents. Patients with this infection usually have asymptomatic viremia and/or nephritis with or without worsening of renal function. The diagnosis of this disease is based on detecting the virus or its effects in urine, blood, and renal tissue. In the past, approximately 30 to 60% of patients with BK virus nephritis developed graft failure. In recent years, the combination of early detection, prompt diagnosis, and therapies including preventive measures have resulted in better outcomes.

Entities:  

Mesh:

Year:  2008        PMID: 18309005      PMCID: PMC3152275          DOI: 10.2215/CJN.02770707

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  63 in total

Review 1.  Polyomavirus BK nephropathy: a (re-)emerging complication in renal transplantation.

Authors:  Hans H Hirsch
Journal:  Am J Transplant       Date:  2002-01       Impact factor: 8.086

2.  Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients.

Authors:  Dirk R J Kuypers; Ann-Karolien Vandooren; Evelyne Lerut; Pieter Evenepoel; Kathleen Claes; Robert Snoeck; Lieve Naesens; Yves Vanrenterghem
Journal:  Am J Transplant       Date:  2005-08       Impact factor: 8.086

3.  New human papovavirus (B.K.) isolated from urine after renal transplantation.

Authors:  S D Gardner; A M Field; D V Coleman; B Hulme
Journal:  Lancet       Date:  1971-06-19       Impact factor: 79.321

4.  Rapid kidney allograft failure in patients with polyoma virus nephritis with prior treatment with antilymphocyte agents.

Authors:  Syed Hussain; Barbara A Bresnahan; Eric P Cohen; Sundaram Hariharan
Journal:  Clin Transplant       Date:  2002-02       Impact factor: 2.863

5.  Polyomavirus nephropathy in native kidneys of non-renal transplant recipients.

Authors:  Ajit P Limaye; Kelly D Smith; Linda Cook; Debra A Groom; Nicholas C Hunt; Keith R Jerome; Michael Boeckh
Journal:  Am J Transplant       Date:  2005-03       Impact factor: 8.086

6.  BK nephropathy in kidney transplant recipients treated with a calcineurin inhibitor-free immunosuppression regimen.

Authors:  Gerald S Lipshutz; Stuart M Flechner; Mahendra V Govani; Flavio Vincenti
Journal:  Am J Transplant       Date:  2004-12       Impact factor: 8.086

7.  Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy.

Authors:  Christopher K Buehrig; Donna J Lager; Mark D Stegall; Michelle A Kreps; Walter K Kremers; James M Gloor; Thomas R Schwab; Jorge A Velosa; Mary E Fidler; Timothy S Larson; Matthew D Griffin
Journal:  Kidney Int       Date:  2003-08       Impact factor: 10.612

8.  Treatment of renal allograft polyoma BK virus infection with leflunomide.

Authors:  Michelle A Josephson; Daniel Gillen; Basit Javaid; Pradeep Kadambi; Shane Meehan; Preston Foster; Robert Harland; Richard J Thistlethwaite; Marc Garfinkel; Walter Atwood; Joslynn Jordan; Molly Sadhu; Michael J Millis; James Williams
Journal:  Transplantation       Date:  2006-03-15       Impact factor: 4.939

9.  Polyomavirus allograft nephropathy: sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression.

Authors:  Betul Celik; Ron Shapiro; Abhay Vats; Parmjeet S Randhawa
Journal:  Am J Transplant       Date:  2003-11       Impact factor: 8.086

10.  Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors.

Authors:  Maurizio Provenzano; Laura Bracci; Stephen Wyler; Tvrtko Hudolin; Giovanni Sais; Rainer Gosert; Paul Zajac; Giorgio Palu'; Michael Heberer; Hans H Hirsch; Giulio C Spagnoli
Journal:  J Transl Med       Date:  2006-11-10       Impact factor: 5.531

View more
  29 in total

1.  Gene therapy to the kidney using viral vectors.

Authors:  Talha Akbulut; Frank Park
Journal:  Paidiatrike       Date:  2008

2.  Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation.

Authors:  Steven Gabardi; Sushrut S Waikar; Spencer Martin; Keri Roberts; Jie Chen; Lea Borgi; Hussein Sheashaa; Christine Dyer; Sayeed K Malek; Stefan G Tullius; Nidyanandh Vadivel; Monica Grafals; Reza Abdi; Nader Najafian; Edgar Milford; Anil Chandraker
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-27       Impact factor: 8.237

3.  Polyomavirus nephropathy of the native kidney in a patient with rheumatoid arthritis and pulmonary fibrosis.

Authors:  Melissa Krystel-Whittemore; Ellen T McCarthy; Ivan Damjanov; Timothy A Fields
Journal:  BMJ Case Rep       Date:  2015-08-28

4.  Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients.

Authors:  Adnan Sharif; Nada Alachkar; Serena Bagnasco; Duvuru Geetha; Gaurav Gupta; Karl Womer; Lois Arend; Lorraine Racusen; Robert Montgomery; Edward Kraus
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 8.237

Review 5.  Mechanisms of BK virus infection of renal cells and therapeutic implications.

Authors:  Christiane Mbianda; Ashraf El-Meanawy; Andrey Sorokin
Journal:  J Clin Virol       Date:  2015-08-06       Impact factor: 3.168

6.  BK virus replication in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.

Authors:  D Geetha; S M Levine; R L Manno; A Valsamakis; S Ghazarian; P Seo
Journal:  Am J Nephrol       Date:  2013-12-31       Impact factor: 3.754

7.  Validated Models of Immune Response to Virus Infection.

Authors:  Amber M Smith
Journal:  Curr Opin Syst Biol       Date:  2018-10-31

8.  The impact of recipient BKV shedding before transplant on BKV viruria, DNAemia, and nephropathy post-transplant: A prospective study.

Authors:  P S Verghese; D O Schmeling; E A Filtz; A J Matas; H H Balfour
Journal:  Pediatr Transplant       Date:  2017-05-29

Review 9.  Recent developments in kidney transplantation--a critical assessment.

Authors:  K L Womer; B Kaplan
Journal:  Am J Transplant       Date:  2009-05-13       Impact factor: 8.086

Review 10.  Immunosuppressive drugs in kidney transplantation: impact on patient survival, and incidence of cardiovascular disease, malignancy and infection.

Authors:  Roberto Marcén
Journal:  Drugs       Date:  2009-11-12       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.